Neurobiological Biomarkers
Post-Acute Neuroadaptation & Dopamine Resensitization
Dopamine D2 Receptor Recovery
65%
Endorphin Tone Index
58% (Moderate upregulation)
Cortisol Stress Reactivity
38% (Stabilizing toward baseline)
Prefrontal Executive Control
70% Restored
Clinical Profile & Protocol
Day 90 Target
At 90 days, baseline dopamine D2 receptor availability increases significantly (~65% of baseline), reducing craving intensity while prefrontal emotional regulation pathways begin sustained structural remodeling.
PAWS Risk Status: Moderate (Anhedonia, Sleep Architecture Recalibration, Latent Craving Triggers)
Post-acute withdrawal manifests as intermittent emotional flatlining or craving waves triggered by conditioned environmental cues.